Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity

Prostate International - Tập 8 - Trang 152-157 - 2020
Abdullah Gul1, Soner Coban1, Ali Riza Turkoglu1, Muhammet Guzelsoy1, Murat Ozturk1, Nazim Abdulkadir Kankilic2
1University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Department of Urology, Bursa, Turkey
2University of Health Sciences, Van Education and Research Hospital, Department of Urology, Van, Turkey

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Prostate International

Tập 8

152-157

Thông tin tác giả